Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose + metformin vs metformin in inadequately controlled type 2 diabetes
CTR20170633Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2017
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by Bayer. Started Nov 2017; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170633.